OPKO Health
OPK
#6153
Rank
NZ$1.49 B
Marketcap
NZ$1.95
Share price
-2.56%
Change (1 day)
-38.89%
Change (1 year)

P/S ratio for OPKO Health (OPK)

P/S ratio as of March 2026 (TTM): 1.38

According to OPKO Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.6763. At the end of 2025 the company had a P/S ratio of 1.79.

P/S ratio history for OPKO Health from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20251.7928.39%
20241.403.29%
20231.3540.55%
20220.9618-47.91%
20211.850.16%
20201.8468.88%
20191.09-38.74%
20181.78-35.06%
20172.74-35.33%
20164.24-61.9%
201511.1-76.49%
201447.431.35%
201336.115.46%
201231.2-38.54%
201150.889.59%
201026.8-24.09%
200935.33.57%
200834.1
200358.6824.51%
20026.34-84.32%
200140.4

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.21 351.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.25 209.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
5.49 299.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.47 79.54%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
1.59 15.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
13.0 848.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1.98 44.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
3.35 143.42%๐Ÿ‡บ๐Ÿ‡ธ USA